Science-Business eXchange

, Volume 4, Issue 31, pp 868–868 | Cite as

ROS overload

  • Joanne Kotz


Boston researchers have identified a molecule that kills tumors by boosting their already high levels of reactive oxygen species, highlighting the potential of targeting oxidative stress pathways in cancer. The scientists have formed Canthera Therapeutics to develop drug-like analogs.

Copyright information

© Nature Publishing Group 2011

Authors and Affiliations

  • Joanne Kotz

There are no affiliations available

Personalised recommendations